Bryan Anderson is the Executive Vice-President & Market Strategist with Beck Capital Management.

Hedge Funds Suffer Massive Redemptions

The hedge fund business continues to hemorrhage assets – over $16 billion in the last six months.  “As a group, hedge funds have suffered horrid performance for more than two years,” said Bryan Anderson, Vice-President & Market Strategist for Beck Capital Management.  “Valeant Pharmaceuticals was a favorite of hedge funds beginning early in 2013.  Last year it imploded and…